Navigation Links
Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013
Date:4/22/2013

MOUNTAIN VIEW, Calif., April 22, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2013 on Thursday, May 9, 2013, following the close of the U.S. financial markets.  The Company will also host an investor conference call and live webcast on the same day at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to provide a company update and discuss the financial results. 

To access the conference call and webcast via the Internet, go to www.alexza.com, under the "Investor Relations" link.  Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required.  Interested parties may also pre-register at https://www.theconferencingservice.com/prereg/key.process?key=PGMFTRGGW.

To access the live conference call, dial 888-680-0865 (domestic) or +1-617-213-4853 (international).  The reference number to enter the call is 11579408.

The replay of the conference call may be accessed at www.alexza.com under the "Investor Relations" link, or by dialing 888-286-8010 (domestic) or +1-617-801-6888 (international).  The reference number for the replay of the call is 72153700.  A replay of the call will be available for two months following the event.

About Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals is focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions, including agitation, acute repetitive seizures and insomnia.  Alexza's products are based on the Staccato® system, a hand-held inha
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
2. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
3. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
4. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
5. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
6. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
7. Alexza Announces Management Promotions
8. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
9. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
10. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
11. Alexza Receives Complete Response Letter for Adasuveā„¢ NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 MiMedx Group, Inc. (NASDAQ: ... marketer of patent protected regenerative biomaterials and bioimplants ... it has entered into a distribution agreement with ... its dehydrated human amnion/chorion membrane ("dHACM") allograft products ... a private label basis. The MiMedx ...
(Date:9/18/2014)... 2014  Zacks.com announces the list of stocks featured ... Research analysts discuss the latest news and events impacting ... the blog include the Avanir Pharmaceuticals (Nasdaq: AVNR - ... Free Report ), Orexigen (Nasdaq: OREX - Free ... ) and Gilead (Nasdaq: GILD - Free Report ...
(Date:9/18/2014)... YORK and PLAINSBORO, N.J. ... announced today its support of the National Hemophilia ... Care , which provides support to people with ... physical and psychosocial challenges that can impede disease ... six modules, Communication With Your Provider About ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3
... level of blood oxygenation can be an essential ... in the clinical setting is often desirable. In ... technology into easily used point-of-care devices, recent products ... values., ,HemoCue, Inc., Lake Forest, Calif., says that ...
... the context of many clinical laboratories, automated production in ... years. In automobile assembly, for example, automated lines fabricate ... The result has been vastly improved products, far fewer ... These days, only a handful of luxury and sports ...
Cached Medicine Technology:Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4
(Date:9/19/2014)... September 19, 2014 One of the ... of bioactive material, making it useful in different application ... and tissue engineering. , Analysts forecast the Global ... of 13.30 percent over the period 2013-2018. According to ... the major drivers in the market. There will be ...
(Date:9/19/2014)... Ohio Couples and other adult family members living ... as adults living with young children or adolescents to ... the week, new research suggests. , The study is ... American adults. While a substantial amount of research has ... family meals, such eating patterns have not been widely ...
(Date:9/19/2014)... CA (PRWEB) September 19, 2014 AttorneyOne.com, a ... the latest information from the FDA on Potassium Chloride ... Baxter International Inc. recalled one lot of Potassium ... on the shipping cartons. Potassium Chloride, administered intravenously, is used ... recall is based on a labeling error on the shipping ...
(Date:9/19/2014)... 19, 2014 Final Cut Pro X plugin ... the Float Theme template for Apple's Final Cut Pro ... template that allows FCPX users to create a professional themed ... Austin, CEO of Pixel Film Studios, "With 48 camera options ... with the Float Theme." , Float features all of ...
(Date:9/19/2014)... Yisrayl Hawkins, Pastor of The House of Yahweh wrote ... protect children. He begins by encouraging the reader not to ... there are many other children, like Michael Brown, who are ... than cancer all over the world and must be stopped ... billion Michaels in the world who were left to themselves ...
Breaking Medicine News(10 mins):Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 3Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 4Health News:Even without kids, couples eat frequent family meals 2Health News:Even without kids, couples eat frequent family meals 3Health News:Even without kids, couples eat frequent family meals 4Health News:Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Pixel Film Studios Releases Float Theme for Final Cut Pro X Users 2Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2
... 4 p.m. EDT) Myelodysplastic syndromes (MDS) a group of ... common in seniors than previously thought, according to a new ... Hackensack University Medical Center. The study also showed for ... risk for heart attack, diabetes and other serious complications than ...
... blockages , MONDAY, April 26 (HealthDay News) -- It,s ... other parts of the body, and researchers now have ... smoking causes progressive stiffening of the arteries. , ... double the speed of those of nonsmokers, Japanese researchers ...
... vital ingredient, researchers believe , MONDAY, April 26 (HealthDay ... rice -- may reduce the risk of heart disease and ... those conditions, research suggests., , In a new study, researchers ... better than white rice when it comes to protecting the ...
... mishaps increase along with distractions, study finds , MONDAY, ... during taxi, takeoff or landing could lead to a ... who prepare and administer medication to hospital patients. ... they,re tending to patients, medication needs increases the chances ...
... Society for Radiation Oncology (ASTRO) applauds President Obama,s selection ... of the Centers for Medicare and Medicaid Services. ASTRO ... administration and Congress to implement critical healthcare reforms for ... across providers to improve the quality of care patients ...
... The American Society of Pediatric Otolaryngology (ASPO) will hold ... the 2010 Combined Otolaryngology Spring Meetings (COSM) - a ... NV. During the ASPO meeting, hundreds of ... featuring expert panelists will be presented focusing on children,s ...
Cached Medicine News:Health News:MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought 2Health News:MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought 3Health News:Arteries Age Twice as Fast in Smokers 2Health News:Arteries Age Twice as Fast in Smokers 3Health News:Interrupting a Nurse Makes Medication Errors More Likely 2Health News:Interrupting a Nurse Makes Medication Errors More Likely 3Health News:Interrupting a Nurse Makes Medication Errors More Likely 4Health News:Scientific meeting will host new research in children's ear, nose and throat health 2
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... best value in high performance electronic pipetting!, ... lightweight design reduce hand fatigue and strain ... tip ejector , Color coding for easy ... for greater performance use Hamilton AdvanTip Low ...
... The Finnpipette BioControl ... innovative features as the ... universal handle fits all ... single channel tip cone ...
... Entire Column of a 384 Well Plate at ... 384 well plates, you need a pipettor that ... exactly what you get with our 16-channel Impact ... Impact/Impact2), this innovation was specifically designed to allow ...
Medicine Products: